FOCUS ISSUE: BIOMARKERS IN CARDIOVASCULAR DISEASE: CLINICAL RESEARCH: BIOMARKERS IN ACS
Copeptin Improves Early Diagnosis of Acute Myocardial Infarction
Till Keller, MD*,
Stergios Tzikas, MD*,
Tanja Zeller, PhD*,
Ewa Czyz, MD*,
Lars Lillpopp*,
Francisco M. Ojeda, PhD*,
Alexander Roth, PhD*,
Christoph Bickel, MD ,
Stephan Baldus, MD ,
Christoph R. Sinning, MD*,
Philipp S. Wild, MD*,
Edith Lubos, MD*,||,
Dirk Peetz, MD ,
Jan Kunde, PhD¶,
Oliver Hartmann, MSc¶,
Andreas Bergmann, PhD¶,
Felix Post, MD*,
Karl J. Lackner, MD ,
Sabine Genth-Zotz, MD*,
Viviane Nicaud, MA#,
Laurence Tiret, PhD#,
Thomas F. Münzel, MD* and
Stefan Blankenberg, MD*,*
* Department of Medicine II, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Institute for Clinical Chemistry and Laboratory Medicine, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
Department of Internal Medicine, Federal Armed Hospital, Koblenz, Germany
Department of Cardiology, Heart Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany
|| Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
¶ B.R.A.H.M.S. AG, Henningsdorf, Germany
# INSERM, UMRS 937, Université Pierre et Marie Curie, Paris, France
Manuscript received October 22, 2009;
revised manuscript received December 17, 2009,
accepted January 2, 2010.
* Reprint requests and correspondence: Dr. Stefan Blankenberg, Department of Medicine II, Johannes Gutenberg-University, Langenbeckstrasse 1, 55101 Mainz, Germany (Email: stefan.blankenberg{at}unimedizin-mainz.de).
Objectives: Early identification of myocardial infarction in chest pain patients is crucial to identify patients at risk and to maintain a fast treatment initiation.
Background: The aim of the current investigation is to test whether determination of copeptin, an indirect marker for arginin-vasopressin, adds diagnostic information to cardiac troponin in early evaluation of patients with suspected myocardial infarction.
Methods: Between January 2007 and July 2008, patients with suspected acute coronary syndrome were consecutively enrolled in this multicenter study. Copeptin, troponin T (TnT), myoglobin, and creatine kinase-myocardial band were determined at admission and after 3 and 6 h.
Results: Of 1,386 (66.4% male) enrolled patients, 299 (21.6%) had the discharge diagnosis of acute myocardial infarction, 184 (13.3%) presented with unstable angina, and in 903 (65.2%) an acute coronary syndrome could be excluded. Combined measurement of copeptin and TnT on admission improved the c-statistic from 0.84 for TnT alone to 0.93 in the overall population and from 0.77 to 0.9 in patients presenting within 3 h after chest pain onset (CPO) (p < 0.001). In this group the combination of copeptin with a conventional TnT provided a negative predictive value of 92.4%.
Conclusions: In triage of chest pain patients, determination of copeptin in addition to troponin improves diagnostic performance, especially early after CPO. Combined determination of troponin and copeptin provides a remarkable negative predictive value virtually independent of CPO time and therefore aids in early and safe rule-out of myocardial infarction.
Key Words: chest pain copeptin diagnosis myocardial infarction troponin
|
Abbreviations and Acronyms
| | ACS = acute coronary syndrome | | AMI = acute myocardial infarction | | AUC = area under the curve | | AVP = arginin-vasopressin | | CK-MB = creatine kinase-myocardial band | | CPO = chest pain onset | | CV = coefficient of variation | | ECG = electrocardiogram/electrocardiographic | | MI = myocardial infarction | | NCCP = noncoronary chest pain | | NPV = negative predictive value | | NT-proBNP = N-terminal pro-brain natriuretic peptide | | PPV = positive predictive value | | ROC = receiver operating characteristic | | TnI = troponin I | | TnT = troponin T | | UAP = unstable angina pectoris |
|
Related Article
-
Inside This Issue
J. Am. Coll. Cardiol. 2010 55: A34.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
N. Schaub, T. Reichlin, R. Twerenbold, M. Reiter, S. Steuer, S. Bassetti, C. Stelzig, C. Wolf, K. Winkler, P. Haaf, et al.
Growth Differentiation Factor-15 in the Early Diagnosis and Risk Stratification of Patients with Acute Chest Pain
Clin. Chem.,
February 1, 2012;
58(2):
441 - 449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mockel
Copeptin Adds to High-Sensitivity Troponin T in Rapid Rule Out of Acute Myocardial Infarction
Clin. Chem.,
January 1, 2012;
58(1):
306 - 307.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. von Haehling, T. Stojakovic, and B. Bigalke
Copeptin--A Novel Marker in Acute Myocardial Infarction
Clin. Chem.,
January 1, 2012;
58(1):
307 - 309.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Karakas, J. L. Januzzi Jr., U. Hoffmann, and W. Koenig
In Reply
Clin. Chem.,
January 1, 2012;
58(1):
309 - 311.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mueller
Counterpoint: Detection of Myocardial Infarction--Is It All Troponin? Role of New Markers
Clin. Chem.,
January 1, 2012;
58(1):
162 - 164.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Keller, T. Zeller, F. Ojeda, S. Tzikas, L. Lillpopp, C. Sinning, P. Wild, S. Genth-Zotz, A. Warnholtz, E. Giannitsis, et al.
Serial Changes in Highly Sensitive Troponin I Assay and Early Diagnosis of Myocardial Infarction
JAMA,
December 28, 2011;
306(24):
2684 - 2693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Giannitsis, T. Kehayova, M. Vafaie, and H. A. Katus
Combined Testing of High-Sensitivity Troponin T and Copeptin on Presentation at Prespecified Cutoffs Improves Rapid Rule-Out of Non-ST-Segment Elevation Myocardial Infarction
Clin. Chem.,
October 1, 2011;
57(10):
1452 - 1455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Karakas, J. L. Januzzi Jr., J. Meyer, H. Lee, C. L. Schlett, Q. A. Truong, W. Rottbauer, F. Bamberg, S. Dasdemir, U. Hoffmann, et al.
Copeptin Does Not Add Diagnostic Information to High-Sensitivity Troponin T in Low- to Intermediate-Risk Patients with Acute Chest Pain: Results from the Rule Out Myocardial Infarction by Computed Tomography (ROMICAT) Study
Clin. Chem.,
August 1, 2011;
57(8):
1137 - 1145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Tentzeris, R. Jarai, S. Farhan, T. Perkmann, M. A. Schwarz, G. Jakl, J. Wojta, and K. Huber
Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure
Eur J Heart Fail,
July 1, 2011;
13(7):
726 - 733.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Benzing, S. Wellmann, F. Achini, J. Letzner, T. Burkhardt, E. Beinder, N. G. Morgenthaler, U. Haagen, H. U. Bucher, C. Buhrer, et al.
Plasma Copeptin in Preterm Infants: A Highly Sensitive Marker of Fetal and Neonatal Stress
J. Clin. Endocrinol. Metab.,
June 1, 2011;
96(6):
E982 - E985.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Alehagen, U. Dahlstrom, J. F. Rehfeld, and J. P. Goetze
Association of Copeptin and N-Terminal proBNP Concentrations With Risk of Cardiovascular Death in Older Patients With Symptoms of Heart Failure
JAMA,
May 25, 2011;
305(20):
2088 - 2095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Balanescu, P. Kopp, M. B. Gaskill, N. G. Morgenthaler, C. Schindler, and J. Rutishauser
Correlation of Plasma Copeptin and Vasopressin Concentrations in Hypo-, Iso-, and Hyperosmolar States
J. Clin. Endocrinol. Metab.,
April 1, 2011;
96(4):
1046 - 1052.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|